Stay updated on Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed; the earlier government funding/operating status notice (Revision: v3.4.1) has been removed. This is an administrative update and does not affect the study details.
    Difference
    0.4%
    Check dated 2026-02-11T11:52:16.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a site-wide notice about potential delays due to government funding and the NIH Clinical Center status. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:28:41.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The additions and deletions are minor metadata and UI updates, including showing the glossary, new 'Last Update' fields, and a revision bump from v3.3.4 to v3.4.0, with some metadata items removed or reformatted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:10:59.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added Principal Investigator: Timothy Voorhees, MD, and protocol implementation contact details (CTO.Implementation@osumc.edu; 614-293-3717) for Ohio State University Comprehensive Cancer Center. Expanded the Locations/Recruiting sections to six sites with explicit Columbus, Ohio addresses and updated recruitment status.
    Difference
    1%
    Check dated 2026-01-21T04:24:21.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 updates the page from v3.3.3; no study content or eligibility details appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:44:16.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now includes a dedicated Locations section listing study sites in Illinois, Indiana, Iowa, Minnesota, and Wisconsin. The separate Illinois Locations entry and related footer label have been removed as part of this update.
    Difference
    0.6%
    Check dated 2025-12-23T20:22:27.000Z thumbnail image

Stay in the know with updates to Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ruxolitinib in Hodgkin Lymphoma Clinical Trial page.